Loading clinical trials...
Loading clinical trials...
NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation
NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations
The primary objective of this study is to confirm the safety and performance of NXT urodynamic system for the intended patient populations, medically indicated for urodynamic study.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Chesapeake Urology Hanover
Hanover, Maryland, United States
Chesapeake Urology Owing Mills
Owing Mills, Maryland, United States
Ohio State University
Columbus, Ohio, United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
June 18, 2024
Primary Completion Date
November 1, 2025
Completion Date
December 1, 2025
Last Updated
February 26, 2025
180
ESTIMATED participants
Urodynamic procedure
DIAGNOSTIC_TEST
Lead Sponsor
Laborie Medical Technologies Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01953263